Quantitative Investment Management LLC Makes New $1.85 Million Investment in Cardinal Health, Inc. $CAH

Key Points

• Quantitative Investment Management LLC acquired 13,393 shares of Cardinal Health, valued at approximately $1.845 million, marking a significant new investment during the 1st quarter.
• Numerous institutional investors increased their stakes in Cardinal Health, resulting in 87.17% of the stock being owned by institutions.
• Analysts have a consensus rating of "Moderate Buy" for Cardinal Health, with target prices varying from $163.20 to $185.00, indicating positive expectations for the company’s stock performance.

Quantitative Investment Management LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 13,393 shares of the company's stock, valued at approximately $1,845,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. acquired a new position in Cardinal Health in the first quarter valued at about $26,000. Tompkins Financial Corp grew its stake in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the period. Bellwether Advisors LLC acquired a new position in Cardinal Health in the fourth quarter valued at about $32,000. GW&K Investment Management LLC grew its stake in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares during the period. Finally, Itau Unibanco Holding S.A. acquired a new position in Cardinal Health in the fourth quarter valued at about $36,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of NYSE CAH traded down $0.92 during trading hours on Friday, reaching $148.60. 1,061,982 shares of the stock were exchanged, compared to its average volume of 2,418,873. The firm has a market capitalization of $35.48 billion, a price-to-earnings ratio of 23.04, a P/E/G ratio of 1.26 and a beta of 0.67. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44. The stock's fifty day simple moving average is $157.70 and its 200 day simple moving average is $145.90.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter last year, the company earned $1.84 EPS. The company's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

Insider Transactions at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of the firm's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares of the company's stock, valued at $30,008,000. This trade represents a 15.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Wells Fargo & Company reaffirmed an "overweight" rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Citigroup reissued a "neutral" rating and set a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Finally, Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.